Your browser doesn't support javascript.
loading
The variants question: What is the problem?
Zella, Davide; Giovanetti, Marta; Benedetti, Francesca; Unali, Francesco; Spoto, Silvia; Guarino, Michele; Angeletti, Silvia; Ciccozzi, Massimo.
Afiliação
  • Zella D; Department of Biochemistry and Molecular Biology, Institute of Human Virology and Global Virus Network Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Giovanetti M; Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Benedetti F; Laboratório de Genética Celular e Molecular, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Unali F; Department of Biochemistry and Molecular Biology, Institute of Human Virology and Global Virus Network Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Spoto S; Area Comunicazione e Brand Management, University Campus Bio-Medico of Rome, Rome, Italy.
  • Guarino M; Department of Diagnostic and Therapeutic Medicine, University Campus Bio-Medico of Rome, Rome, Italy.
  • Angeletti S; Department of Gastrointestinal Diseases, Campus Bio-Medico University, Rome, Italy.
  • Ciccozzi M; Unit of Clinical Laboratory Science, University Campus Bio-Medico of Rome, Rome, Italy.
J Med Virol ; 93(12): 6479-6485, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34255352
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in Wuhan, China in early December 2019 has rapidly widespread worldwide. Over the course of the pandemic, due to the advance of whole-genome sequencing technologies, an unprecedented number of genomes have been generated, providing both invaluable insights into the ongoing evolution and epidemiology of the virus and allowing the identification of hundreds of circulating genetic variants during the pandemic. In recent months variants of SARS-CoV-2 that have an increased number of mutations on the Spike protein have brought concern all over the world. These have been called "variants of concerns" (VOCs), and/or "variants of interests" (VOIs) as it has been suggested that their genome mutations might impact transmission, immune control, and virulence. Tracking the spread of emerging SARS-CoV-2 variants is crucial to inform public health efforts and control the ongoing pandemic. In this review, a concise characterization of the SARS-CoV-2 mutational patterns of the main VOCs and VOIs circulating and cocirculating worldwide has been presented to determine the magnitude of the SARS-CoV-2 threat to better understand the virus genetic diversity and its potential impact on vaccination strategy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos